BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26478444)

  • 1. Seizures in oligodendroglial tumors.
    Kerkhof M; Benit C; Duran-Pena A; Vecht CJ
    CNS Oncol; 2015; 4(5):347-56. PubMed ID: 26478444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seizure characteristics and prognostic factors of gliomas.
    Kerkhof M; Vecht CJ
    Epilepsia; 2013 Dec; 54 Suppl 9():12-7. PubMed ID: 24328866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seizures and Anticonvulsants in Brain Tumours: Frequency, Mechanisms and Anti-Epileptic Management.
    Vecht C; Royer-Perron L; Houillier C; Huberfeld G
    Curr Pharm Des; 2017; 23(42):6464-6487. PubMed ID: 29076421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seizures in low- and high-grade gliomas: current management and future outlook.
    Vecht CJ; Wilms EB
    Expert Rev Anticancer Ther; 2010 May; 10(5):663-9. PubMed ID: 20469999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous and oral levetiracetam in patients with a suspected primary brain tumor and symptomatic seizures undergoing neurosurgery: the HELLO trial.
    Bähr O; Hermisson M; Rona S; Rieger J; Nussbaum S; Körtvelyessy P; Franz K; Tatagiba M; Seifert V; Weller M; Steinbach JP
    Acta Neurochir (Wien); 2012 Feb; 154(2):229-35; discussion 235. PubMed ID: 21909835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seizure prognosis in brain tumors: new insights and evidence-based management.
    Vecht CJ; Kerkhof M; Duran-Pena A
    Oncologist; 2014 Jul; 19(7):751-9. PubMed ID: 24899645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seizures in glioma patients: An overview of incidence, etiology, and therapies.
    Samudra N; Zacharias T; Plitt A; Lega B; Pan E
    J Neurol Sci; 2019 Sep; 404():80-85. PubMed ID: 31352293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid.
    van der Meer PB; Dirven L; Fiocco M; Vos MJ; Kouwenhoven MCM; van den Bent MJ; Taphoorn MJB; Koekkoek JAF
    Epilepsia; 2021 May; 62(5):1119-1129. PubMed ID: 33735464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and treatment of seizures in patients with high-grade glioma: a review.
    Englot DJ; Berger MS; Chang EF; Garcia PA
    Neurosurg Clin N Am; 2012 Apr; 23(2):227-35, vii-viii. PubMed ID: 22440866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments.
    Rudà R; Bello L; Duffau H; Soffietti R
    Neuro Oncol; 2012 Sep; 14 Suppl 4(Suppl 4):iv55-64. PubMed ID: 23095831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy of epileptic seizures in glioma patients: who, when, why and how long?
    Wick W; Menn O; Meisner C; Steinbach J; Hermisson M; Tatagiba M; Weller M
    Onkologie; 2005 Aug; 28(8-9):391-6. PubMed ID: 16160401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of anti-epileptic therapy management of patients with malignant tumors of the brain undergoing radiation therapy.
    Julie DAR; Ahmed Z; Karceski SC; Pannullo SC; Schwartz TH; Parashar B; Wernicke AG
    Seizure; 2019 Aug; 70():30-37. PubMed ID: 31247400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Management of Seizures in Patients With Low-Grade Glioma.
    Piotrowski AF; Blakeley J
    Semin Radiat Oncol; 2015 Jul; 25(3):219-24. PubMed ID: 26050593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of cannabidiol for seizure control in a patient with recurrent glioma.
    Hsu K; Whitham E; Kichenadasse G
    J Clin Neurosci; 2020 Jan; 71():275-276. PubMed ID: 31848037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seizure characteristics and control following resection in 332 patients with low-grade gliomas.
    Chang EF; Potts MB; Keles GE; Lamborn KR; Chang SM; Barbaro NM; Berger MS
    J Neurosurg; 2008 Feb; 108(2):227-35. PubMed ID: 18240916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glioma-associated epilepsy].
    Lian K; Engelsen B; Storstein A
    Tidsskr Nor Laegeforen; 2012 Aug; 132(15):1752-6. PubMed ID: 22929942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing antiepileptic drug treatment in tumoral epilepsy.
    Perucca E
    Epilepsia; 2013 Dec; 54 Suppl 9():97-104. PubMed ID: 24328881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials.
    Avila EK; Chamberlain M; Schiff D; Reijneveld JC; Armstrong TS; Ruda R; Wen PY; Weller M; Koekkoek JA; Mittal S; Arakawa Y; Choucair A; Gonzalez-Martinez J; MacDonald DR; Nishikawa R; Shah A; Vecht CJ; Warren P; van den Bent MJ; DeAngelis LM
    Neuro Oncol; 2017 Jan; 19(1):12-21. PubMed ID: 27651472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seizures and gliomas--towards a single therapeutic approach.
    Huberfeld G; Vecht CJ
    Nat Rev Neurol; 2016 Apr; 12(4):204-16. PubMed ID: 26965673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epilepsy and brain tumors.
    Englot DJ; Chang EF; Vecht CJ
    Handb Clin Neurol; 2016; 134():267-85. PubMed ID: 26948360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.